STE Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
1.6B
+6.2%
1.5B
+2.5%
1.5B
+5.0%
1.4B
-6.0%
1.5B
Cost of Revenue
891.2M
+6.0%
840.7M
+3.2%
814.4M
+6.7%
763.1M
-9.1%
839.3M
Gross Profit
697.2M
+6.4%
655.5M
+1.5%
645.9M
+2.9%
628.0M
-2.1%
641.2M
Operating Expenses
380.3M
-0.5%
382.2M
+0.6%
380.1M
-0.5%
382.0M
-10.1%
425.0M
R&D
28.8M
-2.4%
29.5M
+4.6%
28.2M
+6.8%
26.4M
-4.3%
27.6M
SG&A
351.8M
-0.1%
352.3M
+0.7%
349.7M
-1.2%
353.8M
+6.0%
333.9M
Operating Income
316.9M
+16.0%
273.3M
+2.8%
265.8M
+8.0%
246.0M
+13.8%
216.2M
EBITDA
440.0M
+11.2%
395.7M
+1.5%
389.7M
+6.1%
367.2M
+3.8%
353.8M
Net Income
220.3M
+13.3%
194.5M
+1.0%
192.5M
+8.1%
178.0M
+21.9%
146.0M
EPS (Basic)
$2.26
+15.3%
$1.96
+0.5%
$1.95
+8.3%
$1.80
+20.8%
$1.49
EPS (Diluted)
$2.23
+13.8%
$1.96
+1.0%
$1.94
+8.4%
$1.79
+21.8%
$1.47
Shares (Diluted)
98.6M
+0.0%
98.6M
-0.2%
98.8M
+0.0%
98.8M
-0.1%
98.9M
STERIS (STE) โ€” Financials